| Authors: |
Boeckh M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Xie H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Stevens-Ayers T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sircy L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zamora D; Department of Medicine, City of Hope Medical Center, Duarte, California, USA., Goldman JD; Department of Medicine, University of Washington, Seattle, Washington, USA.; Infectious Disease, Providence Swedish Medical Center, Seattle, Washington, USA., Woods CW; Division of Infectious Diseases, Center for Precision Health, Duke University, Durham, North Carolina, USA., Stapleton RD; Department of Medicine, University of Vermont, Burlington, Vermont, USA., Rubenfeld G; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Kalil A; Division of Infectious Diseases, University of Nebraska, Lincoln, Nebraska, USA., Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Dasgupta S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Limaye AP; Infectious Disease Division, University of California San Francisco, San Francisco, California, USA. |